Skip to content
August 16, 2022

Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform, Accelerate Programs to the Clinic

You are about to leave MPM BioImpact's website. MPM BioImpact is not responsible for the content on other companies' websites.

Cancel Continue